Mark van Geffen

452 total citations
16 papers, 364 citations indexed

About

Mark van Geffen is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Mark van Geffen has authored 16 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Mark van Geffen's work include Hemophilia Treatment and Research (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Platelet Disorders and Treatments (4 papers). Mark van Geffen is often cited by papers focused on Hemophilia Treatment and Research (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Platelet Disorders and Treatments (4 papers). Mark van Geffen collaborates with scholars based in Netherlands, Italy and United States. Mark van Geffen's co-authors include Waander L. van Heerde, Arnoud Loof, Clemens van Blitterswijk, J. Tramper, Dirk E. Martens, Jos Malda, Jens Riesle, Massimo Cugno, Marco Cicardi and Britta A. P. Laros‐van Gorkom and has published in prestigious journals such as Chemistry - A European Journal, Biosensors and Bioelectronics and Osteoarthritis and Cartilage.

In The Last Decade

Mark van Geffen

14 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark van Geffen Netherlands	9	151	97	80	74	56	16	364
Johanna P. van Geffen Netherlands	14	221 1.5×	42 0.4×	67 0.8×	10 0.1×	65 1.2×	17	394
Iván Parra‐Izquierdo United States	11	77 0.5×	27 0.3×	90 1.1×	18 0.2×	66 1.2×	18	335
Sandrine Laurance France	11	120 0.8×	124 1.3×	84 1.1×	9 0.1×	35 0.6×	24	402
Jens Posma Netherlands	6	129 0.9×	41 0.4×	68 0.8×	6 0.1×	28 0.5×	15	299
Zonghong Shao China	9	172 1.1×	46 0.5×	173 2.2×	20 0.3×	39 0.7×	34	342
Yueyue Fu China	9	71 0.5×	43 0.4×	167 2.1×	19 0.3×	66 1.2×	22	340
Inês Mota Portugal	11	91 0.6×	20 0.2×	125 1.6×	21 0.3×	57 1.0×	21	382
S.D. Nandedkar United States	8	51 0.3×	64 0.7×	89 1.1×	7 0.1×	92 1.6×	13	334
H.S. Rosário Portugal	7	67 0.4×	20 0.2×	107 1.3×	122 1.6×	46 0.8×	8	377
Surasak Wichaiyo Thailand	11	138 0.9×	37 0.4×	90 1.1×	6 0.1×	55 1.0×	22	387

Countries citing papers authored by Mark van Geffen

Since Specialization

Citations

This map shows the geographic impact of Mark van Geffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark van Geffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark van Geffen more than expected).

Fields of papers citing papers by Mark van Geffen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark van Geffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark van Geffen. The network helps show where Mark van Geffen may publish in the future.

Co-authorship network of co-authors of Mark van Geffen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark van Geffen. A scholar is included among the top collaborators of Mark van Geffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark van Geffen. Mark van Geffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ridder, C., et al.. (2025). Novel microfluidic device for factor VIII quantification by chemiluminescence in hemophilia A patients. Biosensors and Bioelectronics. 282. 117469–117469.

Geffen, Mark van, et al.. (2023). PB0694 A Chemiluminescent-Based Multiparameter Platform for Simultaneous Measurement of Factor VIII Activity and Thrombin Generation. Research and Practice in Thrombosis and Haemostasis. 7. 101231–101231.

Geffen, Mark van, et al.. (2023). Synthesis and Evaluation of Glycosyl Luciferins. Chemistry - A European Journal. 30(3). e202302547–e202302547. 2 indexed citations

Löwik, Dennis W. P. M., Mark van Geffen, Cornelis van’t Veer, et al.. (2023). Solid-Phase Synthesis of Caged Luminescent Peptides via Side Chain Anchoring. Bioconjugate Chemistry. 34(12). 2234–2242. 1 indexed citations

Merx, Jona, Thomas J. Boltje, Dennis W. P. M. Löwik, et al.. (2022). Luminescent Assay for the Screening of SARS‐CoV‐2 M^Pro Inhibitors. ChemBioChem. 23(15). e202200190–e202200190. 7 indexed citations

Löwik, Dennis W. P. M., Mark van Geffen, Cornelis van’t Veer, et al.. (2022). Activity Sensing of Coagulation and Fibrinolytic Proteases. Chemistry - A European Journal. 29(18). e202203473–e202203473. 9 indexed citations

Schols, Saskia E.M., et al.. (2019). Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency. Haemophilia. 25(6). 1073–1082. 11 indexed citations

Geffen, Mark van, Pål André Holme, Britta A. P. Laros‐van Gorkom, et al.. (2013). Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients. Thrombosis Research. 132(1). 116–122. 9 indexed citations

Geffen, Mark van & Waander L. van Heerde. (2012). Global haemostasis assays, from bench to bedside. Thrombosis Research. 129(6). 681–687. 42 indexed citations

10.

Geffen, Mark van, Marzia Menegatti, Arnoud Loof, et al.. (2012). Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders. Haemophilia. 18(4). 630–638. 28 indexed citations

11.

Geffen, Mark van, et al.. (2011). Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency. Clinical & Experimental Immunology. 167(3). 472–478. 64 indexed citations

12.

Geffen, Mark van, Arnoud Loof, J.B.M. Boezeman, et al.. (2011). A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis. Hematology. 16(6). 327–336. 51 indexed citations

13.

Geffen, Mark van, et al.. (2009). Factor VIII Inhibitor Assays: Methodology, Shortcomings, and Challenges. 5 indexed citations

14.

America, Antoine H. P., Jan Cordewener, Mark van Geffen, et al.. (2005). Alignment and statistical difference analysis of complex peptide data sets generated by multidimensional LC‐MS. PROTEOMICS. 6(2). 641–653. 64 indexed citations

15.

Malda, Jos, Clemens van Blitterswijk, Mark van Geffen, et al.. (2004). Low oxygen tension stimulates the redifferentiation of dedifferentiated adult human nasal chondrocytes. Osteoarthritis and Cartilage. 12(4). 306–313. 69 indexed citations

16.

Malda, Jos, Mark van Geffen, Dirk E. Martens, et al.. (2003). Low oxygen tension stimulates redifferentiation of dedifferentiated adult human nasal chondrocytes. University of Twente Research Information. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact